Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults

P Mariappan, Z Ballantyne, J M O N'Dow, A A Alhasso

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

To date, standard recommendations for the management of stress urinary incontinence (SUI) would be either pelvic floor muscle training (PFMT) or surgery. A new form of drug treatment with a serotonin-noradrenaline reuptake inhibitor (SNRI), duloxetine, may now have a place in treatment of this condition.
Original languageEnglish
Pages (from-to)CD004742
JournalCochrane Database of Systematic Reviews
Issue number3
DOIs
Publication statusPublished - 2005

Fingerprint Dive into the research topics of 'Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults'. Together they form a unique fingerprint.

  • Cite this